Feds passed up chance to lock in more Pfizer vaccine doses
Share
Tweet
December 8, 2020
Gareth Fuller – Associated Press
A pharmacy technician from Croydon Health Services prepares to store the first delivery of COVID-19 vaccine, at Croydon University Hospital in Croydon, England, Saturday Dec. 5, 2020. The first batch of Pfizer COVID-19 vaccine is delivered to the area in preparation for a public inoculation program, with each person needing two injections and the vaccine stored at extremely low temperature.
WASHINGTON - The Trump administration opted last summer not to lock in a chance to buy millions of additional doses of one of the leading coronavirus vaccine contenders, a decision that could delay the delivery of a second batch of doses until manufacturer Pfizer fulfills other international contracts.
The revelation, confirmed Monday by people familiar with the matter, came a day before President Donald Trump aimed to take credit for the speedy development of forthcoming coronavirus vaccines at a White House summit Tuesday.
Pfizer's vaccine is expected to be endorsed by a panel of Food and Drug Administration advisers as soon as this week, with delivery of 100 million doses - enough for 50 million Americans - expected in coming months.
https://www.startribune.com/trump-summit-aims-to-boost-faith-in-vaccine-excludes-biden/573322311/
Reader Comments(0)